INMD
InMode LtdNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$864.85M
P/E Ratio
9.61
EPS
$1.42
Beta
2.12
52W High
$16.74
52W Low
$12.72
50-Day MA
$14.17
200-Day MA
$14.50
Dividend Yield
—
Profit Margin
25.30%
Forward P/E
9.51
PEG Ratio
2.90
About InMode Ltd
InMode Ltd. designs, develops, manufactures and markets minimally invasive aesthetic medical products based on its proprietary RF-assisted lipolysis and deep subdermal fractional RF technologies. The company is headquartered in Yokneam, Israel.
Fundamentals
| Revenue (TTM) | $370.50M |
| Gross Profit (TTM) | $290.97M |
| EBITDA | $86.08M |
| Operating Margin | 25.00% |
| Return on Equity | 13.50% |
| Return on Assets | 6.88% |
| Revenue/Share (TTM) | $5.73 |
| Book Value | $10.78 |
| Price-to-Book | 1.28 |
| Price-to-Sales (TTM) | 2.33 |
| EV/Revenue | 0.882 |
| EV/EBITDA | 3.79 |
| Quarterly Earnings Growth (YoY) | -63.50% |
| Quarterly Revenue Growth (YoY) | 6.10% |
| Shares Outstanding | $63.36M |
| Float | $54.93M |
| % Insiders | 11.36% |
| % Institutions | 56.85% |
Analyst Ratings
Consensus ($17.00 target)
1
Strong Buy6
HoldData last updated: 4/8/2026